Data protection Impressum

Biotech

Researchers at the University of Geneva have uncovered that astrocytes in the brain’s cortex originate from two distinct types of progenitors, a finding that could reshape therapeutic strategies for neurological disorders.

University of Geneva researchers uncover two distinct origins of key brain cells

11 August 2025

Two start-ups from Western Switzerland’s Health Valley, AzureCell Therapies and Myriad Optics, have each been awarded CHF 150,000 through the Gebert Rüf Stiftung’s Innobooster programme, which supports high-potential projects emerging from Swiss universities.

AzureCell Therapies and Myriad Optics awarded by Gebert Rüf Stiftung’s Innobooster programme

11 August 2025

Biopôle has evolved its Start Up Fund into a 24 month scheme combining non dilutive capital, investor training and growth support.

Biopôle launches enhanced Investment Programme to boost life sciences start‑ups

6 August 2025

Oculis expands its loan facility with BlackRock to CHF 100 million, extending its financial runway and supporting late-stage clinical trials.

Oculis secures up to CHF 100 million in expanded loan facility with BlackRock

5 August 2025

Geneva Business School launches Switzerland’s first MBA in Biotech Management, blending business strategy with biotech innovation.

Geneva Business School launches Switzerland’s first MBA in Biotech Management

4 August 2025

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (July 2025)

4 August 2025

Swiss start-ups raised CHF 1.47 billion in the first half of 2025, with biotech and fintech driving growth despite fewer deals and cautious investor sentiment.

Swiss start-ups attract CHF 1.47 billion in first half of 2025

15 July 2025

Neuchâtel, renowned globally for its watchmaking heritage, has evolved into a dynamic hub of cutting-edge innovation. Today, the canton leverages its tradition of precision craftsmanship to excel in fields as diverse as blockchain, quantum technology, renewable energy, life sciences, and advanced manufacturing. The canton of Neuchâtel’s transformation highlights its unique ability to merge historical excellence with visionary innovation, positioning itself as a leading force within Switzerland’s economic landscape.

Neuchâtel, a legacy of precision driving tomorrow’s innovation

Geneva-based biotech Stalicla secures funding to advance precision medicine programs for autism and substance use disorders.

Addex Therapeutics leads CHF 2 million investment in Stalicla

14 July 2025

Biopôle adds 18 new private labs for life sciences scale-ups in Lausanne, offering flexible, plug-and-play infrastructure in the new Trypto building.

Biopôle expands with 18 new private laboratories for life sciences scale-ups

2 July 2025

1 2 3 4 5 … 22